Table 3.

Virologic Outcomes of EI-AED Compared to Non-AED Subjects

	EI-AED (N = 19)	Non-AED (N = 190)	OR (95% CI) or Difference ± SE	Adjusted for VL at HAART Initiation OR (95% CI) or Difference ± SE
First HAART/AED Overlap
Virologic failure	10/16 (62.5%)	62/146 (42.5%)	2.26 (0.78 - 6.54) P = 0.134	4.30 (1.02 - 18.07) P = 0.046
Average VL during period (log10)	3.3 ± 1.3 (n = 19)	2.9 ± 1.2 (n = 184)	0.4 ± 0.3; P = 0.198	0.3 ± 0.3; P = 0.195
VL <400 at 6 months	4/12 (33.3%)	89/160 (55.6%)	0.40 (0.12 - 1.38) P = 0.146	0.30 (0.06 - 1.48) P = 0.139
VL <400 at 12 months	4/11 (36.4%)	80/125 (64.0%)	0.32 (0.09 - 1.16) P = 0.083	0.17 (0.03 - 0.89) P = 0.036

OR (odds ratio): Odds of virologic event for EI-AED cases versus odds for non-AED controls; VL, viral load (copies/mL)